SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFintel Regulatory News (FNTL)

Share Price Information for Fintel (FNTL)

Share Price is delayed by 15 minutes
Get Live Data
181.00    4.50 (2.55%)
Bid:
181.00
Ask:
183.00
Spread: 2.00 (1.105%)
Market Cap: £188.59m
FNTL Live PriceLast checked at - London Stock Exchange

Intraday Fintel Share Chart

Strategic Update & Pre-close Trading Statement

21 Jul 2021 07:00

RNS Number : 9470F
Fintel PLC
21 July 2021
Β 

21 July 2021

Β 

Fintel plc

Β 

("Fintel", the "Company" or the "Business")

Β 

Strategic Update & Pre-close Trading Statement

Β 

Strategic Delivery, Digital Acceleration, Robust TradingΒ 

Β 

Fintel (AIM: FNTL), the leading provider of fintech and support services to the UK retail financial services sector, today issues an update on strategic progress and a pre-close trading update for the six months ended 30 June 2021.

Β 

Strategic Progress

Β· Successfully disposed of non-core Zest Technology for initial cash consideration of Β£10m.

Β 

Financial Highlights

Β· Revenues up 10% to Β£31.7m (H1 2020 Β£28.9m)

Β· Adjusted EBITDA*1 up 12% to Β£8.3m (H1 2020 Β£7.4m)

Β· Strong Adjusted EBITDA*1 margin of 26.1% (H1 2020 25.5%)

Β· Cash flow conversion*2Β expected to exceed 70% (H1 2020: 65%)

Β 

Β 

Disposal of Zest

Β 

The Company today announces that it has agreed the disposal of non-core Zest Technology ("Zest"), a fully owned subsidiary of Fintel plc, to FPE Capital for an initial consideration of Β£10m, representing a disposal multiple of 22 times (22x) trailing EBITDA (12 months ended 30 June 2021). The disposal proceeds may increase by up to a further Β£1.5m based on revenue delivered in FY21. Zest provides software for the employee benefits market, delivered directly to clients and through licensees. The Board believe this represents excellent value for shareholders for a non-core asset.

Β 

Taking into account the net proceeds of the disposal, the Company's pro forma net debt to last 12 months Adjusted EBITDA*1 ratio would have reduced to c.0.3 times (0.3x) as at 30 June 2021.

Β 

Β 

Trading update

Β 

The Business continued to trade well in the first six months of the year, and in line with the Board's overall expectations. Revenues were up 10% year-on-year with Adjusted EBITDA up 12%. The core membership business has been robust and recovery in the housing market and housing related transactions have contributed to overall growth.

Β 

Solid progress has been made on the transition towards our new digital operating model, in particular with respect to distribution revenues. Plans to digitise these services are significantly ahead of initial projections, and a further update on overall digital progress will be provided along with the interim results release scheduled for September 2021.

Β 

Cash conversion continues to be an inherent strength for the business, with in excess of 70% conversion expected to be achieved in the period.

Β 

The Board remains confident of its full year expectations for the business, taking into account the disposal of Zest.

Β 

Notice of Interim Results

Fintel intends to publish its interim results for the six months ended 30 June 2021 on 21 September 2021.

Β 

Matt Timmins, Joint CEO of The SimplyBiz Group plc, said:

"We are delighted to report significant strategic progress and strong trading across the first six months of the year. We have successfully sold Zest Technology for an excellent price, allowing us to streamline the business in line with our strategy to focus on our core, and create funding headroom to support our future growth.

Β 

Our ongoing and rapid digital acceleration means Fintel continues to grow with real momentum. We're now in an even stronger financial position and developing the business with focus, pace and agility.

Β 

These are exciting times. We are Fintel."

Β 

*1Β Adjusted EBITDA is earnings before interest, tax, depreciation, amortisation, share option charges and operating exceptional costs.

*2 Cash flow conversion is calculated as adjusted EBITDA, less working capital movements, lease payments, CAPEX, development expenditure, corporation tax payable and interest, as a percentage of Adjusted EBITDA.

Β 

Β 

For further information please contact:

Β 

FintelΒ plc via Instinctif Partners

Matt Timmins (Joint Chief Executive Officer)

Neil Stevens (Joint Chief Executive Officer)

Β 

Zeus Capital (Nominated Adviser and Joint Broker) +44 (0) 20 3829 5000

Martin Green

Dan Bate

Pippa HamnettΒ 

Β 

Investec Bank (Joint Broker) +44 (0) 20 7597 5095

Bruce Garrow

David Anderson

Harry Hargreaves

Β 

Instinctif Partners (Financial PR) +44 (0) 20 7457 2020

Mark Walter fintel@instinctif.com

Lewis HillΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDGUGDRGSDDGBB
Date   Source Headline
18th May 20232:56 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Statement
17th Apr 20231:40 pmRNSHolding(s) in Company
5th Apr 20237:00 amRNSNotice of AGM and Annual Report
23rd Mar 20237:00 amRNSFinal Results Presentations for Retail Investors
22nd Mar 20237:00 amRNSDirector / PDMR Dealing
21st Mar 20235:30 pmRNSReplacement Full Year Results
21st Mar 20237:00 amRNSFull Year Results
26th Jan 20237:00 amRNSTrading Update & Notice of FY Results
8th Dec 20223:53 pmRNSIssue of shares
19th Oct 20227:00 amRNSIssue of shares
13th Oct 20227:00 amRNSExpansion of strategic partnership with Schroders
22nd Sep 20227:00 amRNSInterim Results Presentations for Retail Investors
21st Sep 20229:26 amRNSDirector/PDMR Dealing
20th Sep 20223:26 pmRNSDirector/PDMR Dealing
20th Sep 20227:00 amRNSHalf Year Results
25th Aug 20222:13 pmRNSIssue of shares
28th Jul 20227:00 amRNSTrading Update
27th Jul 20227:00 amRNSDirector/PDMR Dealing
26th Jul 20221:19 pmRNSDirector/PDMR Dealing
25th Jul 20222:14 pmRNSDirector/PDMR Dealing
20th Jul 20229:35 amRNSCorrection: Director / PDMR Dealing
19th Jul 20227:00 amRNSIncreased regulation drives demand for Defaqto
18th Jul 20227:00 amRNSDirector/PDMR Dealing
4th Jul 20221:18 pmRNSIssue of shares
23rd Jun 202211:00 amRNSCorrection: Issue of shares & block listing return
21st Jun 20227:00 amRNSDirector/PDMR Dealing
16th Jun 20224:47 pmRNSIssue of shares and Block listing return
14th Jun 20227:00 amRNSStrategic distribution partnership with M&G plc
17th May 20224:41 pmRNSSecond Price Monitoring Extn
17th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20222:24 pmRNSResult of AGM
17th May 20227:00 amRNSAGM Statement
10th May 202212:55 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSDirectorate Change
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSNotice of AGM
23rd Mar 20227:00 amRNSDirector/PDMR Dealing
22nd Mar 20224:36 pmRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSFull Year Results
17th Feb 20227:00 amRNSFintel expands its Management Distribution Service
7th Feb 20222:24 pmRNSHolding(s) in Company
1st Feb 20224:36 pmRNSPrice Monitoring Extension
27th Jan 20227:00 amRNSTrading Update and notice of Full Year Results
6th Jan 20221:00 pmRNSChange of Auditor
23rd Dec 20218:03 amRNSUpdate on Managed Distribution Service
23rd Dec 20217:00 amRNSUpdate on Managed Distribution Service
14th Dec 20217:00 amRNSBlock listing application
13th Dec 202110:50 amRNSDirector/PDMR Dealing
9th Dec 20217:00 amRNSIssue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.